GH1 and pituitary gland adenoma: The cohort included 303 endocrine-inactive tumors and 181 endocrine-active tumors including 86 GH-secreting pituitary adenomas, 57 prolactinomas, 36 ACTH-secreting pituitary adenomas, 2 TSH-secreting adenomas.